Your browser doesn't support javascript.
loading
Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism.
Nafee, Tarek; Gibson, C Michael; Yee, Megan K; Alkhalfan, Fahad; Chi, Gerald; Travis, Ryan; Mir, Mahshid; Kalayci, Arzu; Jafarizade, Mehrian; Ganti, Aditya; Kazmi, Syed Hassan; Ghaffarpasand, Eiman; Pitliya, Anmol; Datta, Sudarshana; Sharfaei, Sadaf; Alihashemi, Mahda; Elsaiey, Ahmed; Qamar, Iqra; Jahansouz, Mohamadmostafa; Talib, Usama; Kahe, Farima; Habibi, Shaghayegh; Abdelwahed, Mohammed; Tariq, Feham; Kaur, Manpreet; Younes, Ahmed; Walia, Sargun S; Singh, Amandeep; Dildar, Syed Muhammad; Afzal, M Khurram; Kerneis, Mathieu.
Afiliação
  • Nafee T; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Gibson CM; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Yee MK; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Alkhalfan F; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Chi G; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Travis R; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Mir M; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Kalayci A; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Jafarizade M; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Ganti A; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Kazmi SH; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Ghaffarpasand E; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Pitliya A; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Datta S; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Sharfaei S; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Alihashemi M; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Elsaiey A; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Qamar I; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Jahansouz M; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Talib U; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Kahe F; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Habibi S; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Abdelwahed M; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Tariq F; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Kaur M; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Younes A; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Walia SS; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Singh A; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Dildar SM; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Afzal MK; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Kerneis M; a PERFUSE Study Group, Cardiovascular Division, Departments of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
Expert Rev Cardiovasc Ther ; 16(11): 845-855, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30296387

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piridinas / Benzamidas / Tromboembolia Venosa / Inibidores do Fator Xa Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Rev Cardiovasc Ther Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piridinas / Benzamidas / Tromboembolia Venosa / Inibidores do Fator Xa Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Rev Cardiovasc Ther Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos